395 results on '"Puxeddu, Efisio"'
Search Results
2. Classification of Thyroid Diseases Using Machine Learning and Bayesian Graph Algorithms
3. Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019)
4. A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis
5. Molecular Markers in Thyroid Fine-Needle Aspiration Biopsies
6. Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019)
7. Riconoscimento e gestione della “Tempesta tiroidea”
8. Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency
9. A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study
10. Ci mancava anche un problema tiroideo…
11. Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy
12. Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes
13. Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation
14. Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation
15. Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update
16. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
17. B-Raf V600E and thrombospondin-1 promote thyroid cancer progression
18. Riconoscimento e gestione della “Non Thyroidal Illness Syndrome” nel paziente ricoverato
19. Un classificatore prognostico basato sui profili della metilazione del DNA dell’intero genoma nei tumori tiroidei ben differenziati
20. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4)
21. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants
22. Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR ®: Biodistribution, pharmacokinetic features and in vivo antitumor activity
23. Impact of Epithelial–Mesenchymal Immunophenotype on Local Aggressiveness in Papillary Thyroid Carcinoma Invading the Airway
24. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer
25. L’immunità anti-tumorale epitopo-specifica sopprime la diffusione tumorale nel carcinoma papillare della tiroide
26. Trattamento dell’ipotiroidismo subclinico o della ipotiroxinemia in gravidanza
27. La combinazione di un inibitore di BRAF e di un anticorpo anti-PD-L1 potenzia drammaticamente la regressione tumorale e l’immunità anti-tumorale in un modello murino immunocompetente di carcinoma anaplastico della tiroide
28. The Natural History of Benign Thyroid Nodules
29. Estimating risk of recurrence of differentiated thyroid cancer patients: a real-world multicenter validation of the american thyroid association initial risk stratification and dynamic re-assessment after 5 years of follow-up.
30. Immune Landscape of Thyroid Cancers: New Insights
31. BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
32. Clinical implications of BRAF mutation in thyroid carcinoma
33. B-[Raf.sup.V600E] and thrombospondin-1 promote thyroid cancer progression
34. Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Up-Regulated in Thyroid Carcinoma and Drives the Development of an Immunosuppressant Tumor Microenvironment
35. Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
36. INSL4 as prognostic marker for proliferation and invasiveness in Non-Small-Cell Lung Cancer
37. Sunitinib therapy in metastatic papillary thyroid cancer
38. Effetti collaterali endocrinologici degli inibitori dei checkpoint immunitari
39. Associazione della funzione tiroidea materna all’inizio della gravidanza con il QI e la morfologia cerebrale della prole durante l’infanzia: uno studio prospettico di coorte basato sulla popolazione
40. The Stone Guest: How Does pH Affect Binding Properties of PD‐1/PD‐L1 Inhibitors?
41. PD-1 Blockade Delays Tumor Growth by Inhibiting an Intrinsic SHP2/Ras/MAPK Signalling in Thyroid Cancer Cells
42. What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers
43. Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
44. Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer
45. Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors
46. Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years
47. THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside
48. Epigenetic control of INSL4 promotes cell growth and invasiveness in Non-Small-Cell Lung Cancer
49. OR21-07 The 2015 American Thyroid Association Risk Stratification System Is a Predictor of Persistent Disease in Real-World Clinical Practice
50. The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.